instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: A panel of Food and Drug Administration advisers voted unanimously in favor of Amgen’s version of AbbVie’s Humira, a biotech drug that raked in nearly $15 billion last year, according to IMS Health. While not binding, the recommendation likely paves the way for FDA approval of the knockoff drug. For years, biotech drugs faced no competition because there was no regulatory way to approve copycat versions, even after patents had expired. If approved, Amgen’s drug would join a new wave of so-called biosimilars, which have the potential to generate billions in savings for U.S. insurers, doctors and patients. But it could take years for those savings to arrive. Evercore ISI analyst Mark Schoenebaum says the earliest Amgen could launch its product would be March 2017, though that would risk infringing patents which Abbvie says protect its drug until at least 2022. Wall Street analysts expect the patent issue to be fought in court, and then for Amgen’s drug to launch sometime between 2018 and 2022. First approved in 2002, Humira has long been among the most profitable drugs in the world. It accounted for 60 percent of Abbvie’s total revenue last year. The injectable drug, which blocks chemicals linked to inflammation, is approved for multiple uses, including rheumatoid arthritis, Crohn’s disease and psoriasis. Thousand Oaks, Calif-based Amgen is seeking FDA approval to market its version, known only as ABP 501, for seven diseases. Amgen is itself a biotech powerhouse, and it too has medications facing competition from cheaper versions. The company is working to hedge those loses by developing lower-cost versions of competitors’ drugs. Biotech drugs are powerful, injected medicines produced in living cells that are typically much more expensive than traditional, chemical-based drugs. In 2015, six of the 10 top-selling medicines globally were biotech drugs, with more than $56 billion in combined sales. The FDA only approved the first lower-cost biotech drug last March, a Novartis version of the Amgen drug Neupogen. Pfizer won approval to market a second biosimilar in April, a version of Johnson & Johnson’s Remicade, but it is not yet for sale. Questions remain about just how much savings U.S. biosimilars will deliver. Novartis’ Zarxio sells for 15 percent less than the original Neupogen. Experts predict biosimilar discounts of 15 percent to 30 percent in the U.S. In Europe, where governments regulate prices, discounts are higher. Development of lower-cost anti-inflammatory drugs like Humira is considered pivotal in reducing U.S. spending on specialty drugs, which has doubled to $150 billion since 2010, according to IMS Health. On Wednesday, the same panel of FDA advisers will review a Novartis version of Enbrel, which is marketed by Amgen. Claim: Lower-cost biotech drug gets thumbs up from FDA panel.
answer:
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases.


question:
Paragraph: Britain’s legal bookmakers reported high interest Tuesday in the names Alexander, James and Arthur. They also noted speculation about the name Spencer, the maiden name of Harry’s late mother, Princess Diana. Royal babies usually have a string of names, opening the way for endless betting possibilities. “Following a flurry of bets last evening, Alexander is now the new favorite at the top of our name betting and the one we are fearing the most,” said John Hill of the Coral betting agency. Alexander has 4/1 odds at Coral, while Arthur is 6/1 and Albert, James and Spencer are all 8/1. Choosing Spencer as a first or middle name is seen as a way for Harry to honor Diana, who died in a Paris car crash in 1997 when he was only 12. Before he married Meghan last year, Harry spoke about his desire to pay tribute to his mother’s memory during the wedding ceremony. Others believe Meghan could choose a name that reflects her American biracial heritage. One Twitter user suggested Marvin — for the late singer Marvin Gaye. The infant, known only as Baby Sussex for the moment, was born Monday at 5:26 a.m. at a yet-undisclosed location. In a gushing announcement of the birth, Harry said he and Meghan are “thinking” about names and hinted that an announcement might be made Wednesday or shortly thereafter. The couple is also expected to pose with their newborn or release a photo on their Instagram account at some time and to publicly name godparents for the child. The new arrival is the eighth great-grandchild of Queen Elizabeth II, who smiled when asked about the baby’s arrival at a luncheon Tuesday. Asked if life is good, the 93-year-old monarch said: “Yes, thank you.” The baby boy is the first of her great-grandchildren to have an American parent. His mother Meghan is the daughter of a white man and a black woman, bringing a biracial heritage to the House of Windsor. Trevor Phillips, a retired black broadcaster who headed Britain’s Equality and Human Rights Commission, wrote an open letter to the royal baby, saying his arrival reflects British society’s more open attitude nowadays and the increasing inclusiveness of the royal family. “This is a family that lives the reality of a multicultural world daily,” he said. “It’s their job: to interact with people of different backgrounds to themselves on behalf of the nation, and to treat them all with respect. I have to tell you, they are pretty good at it.” He went on to tell the baby: “Whether you like it or not, you’re going to have a special place in the nation’s heart.” Prince William, Harry’s older brother, joked Tuesday that he will be glad “to welcome my own brother into the sleep deprivation society that is parenting!” “Obviously thrilled, absolutely thrilled, and obviously looking forward to seeing them in the next few days when things have quietened down,” William told reporters. The birth produced a moment of high drama likely to be replayed for the rest of Harry’s life. The prince, who has battled mental health challenges since the abrupt loss of his mother at a young age, emerged with the world’s most satisfied grin Monday afternoon to announce the birth of his son before TV news cameras. “We’re both absolutely thrilled and so grateful for all the love and support from everybody out there. It’s been amazing, so we just wanted to share this with everybody,” the normally press-shy royal gushed. Harry also burnished his feminist credentials — and paid tribute to mothers around the world — after witnessing the birth. “It’s been the most amazing experience I could ever have possibly imagined,” he said. “How any woman does what they do is beyond comprehension.” ___ Read all Associated Press coverage of the latest royal baby at https://www.apnews.com/RoyalBaby Claim: Will new royal baby’s name honor Princess Diana? Stay tuned.
answer:
Britons love to lay down their bets — and with the birth of a healthy baby boy for Meghan, the Duchess of Sussex, and Prince Harry, it’s time to focus on boys’ names.


question:
Paragraph: The World Health Organization has so far resisted describing the crisis as such, saying the word “pandemic” might spook the world further and lead some countries to lose hope of containing the virus. “Unless we’re convinced it’s uncontrollable, why (would) we call it a pandemic?” WHO director-general Tedros Adhanom Ghebreyesus said this week. The U.N. health agency has previously described a pandemic as a situation in which a new virus is causing “sustained community-level outbreaks” in at least two world regions. Many experts say that threshold has long been met: The virus that was first identified in China is now spreading freely in four regions, it has reached every continent but Antarctica, and its advance seems unavoidable. The disease has managed to gain a foothold and multiply quickly even in countries with relatively strong public health systems. On Friday, the virus hit a new milestone, infecting more than 100,000 people worldwide, far more than those sickened by SARS, MERS or Ebola in recent years. “I think it’s pretty clear we’re in a pandemic and I don’t know why WHO is resisting that,” said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. Experts acknowledge that declaring a pandemic is politically fraught because it can rattle markets, lead to more drastic travel and trade restrictions and stigmatize people coming from affected regions. WHO was previously criticized for labeling the 2009 swine flu outbreak a pandemic. But experts said calling this crisis a pandemic could also spur countries to prepare for the virus’s eventual arrival. WHO already declared the virus a “global health emergency’ in late January, putting countries and humanitarian organizations on notice and issuing a broad set of recommendations to curb its spread. Even in countries that moved quickly to shut down their links to China, COVID-19 has managed to sneak in. Within a matter of weeks, officials in Italy, Iran and South Korea went from reporting single new cases to hundreds. “We were the first country to stop flights to China and we were completely surprised by this disease,” said Massimo Galli, an infectious-diseases professor at the University of Milan. “It’s dangerous for the entire world that the virus is able to spread underground like this.” With more than 3,800 cases, Italy is the epicenter of Europe’s outbreak and has shut down schools, closed sports stadiums to fans and urged the elderly not to go outside unless absolutely necessary. But it has still exported cases of the virus to at least 10 countries, including Austria, the Czech Republic, Spain, South Africa and Nigeria. Devi Sridhar, a professor of global public health at the University of Edinburgh who co-chaired a review of WHO’s response to the 2014-16 Ebola outbreak in West Africa, said a pandemic declaration is long overdue. “This outbreak meets all the definitions for a pandemic that we had pre-coronavirus,” she said. At a news conference last month, Dr. Mike Ryan, WHO’s emergencies chief, said a pandemic is “a unique situation in which we believe that all citizens on the planet” will likely be exposed to a virus “within a defined period of time.”  Several experts said they hadn’t heard that definition. The U.S. Centers for Disease Control and Prevention, for its part, defines a pandemic as “an epidemic that has spread over several countries or continents, usually affecting a large number of people.” ___ The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Claim: As virus outbreaks multiply, UN declines to declare pandemic.
answer:

As cases of the coronavirus surge in Italy, Iran, South Korea, the U.S. and elsewhere, many scientists say it’s plain that the world is in the grips of a pandemic — a serious global outbreak.